Find in Library

PB1762: PONATINIB VERSUS IMATINIB WITH REDUCED-INTENSITY CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME–POSITIVE (PH+) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): PHALLCON STUDY

oleh: E. Jabbour, G. Martinelli, M. Vignetti, H. Kantarjian, D. Gomez-Almaguer, Y. Minami, H. Dombret, M. Hennessy, A. Vorog, B. Wang, J.-M. Ribera